2023 Cholesterol Summit

Join us for a non-CE* event to learn how to apply evidence-based lipid management strategies in your nursing practice.  The American Heart Association estimates that nearly 94 million American adults have elevated blood cholesterol levels.  Despite advances in the pharmacological treatment of dyslipidemia, high cholesterol remains a significant public health problem across the United States.

Agenda

9:00 AM CT	Welcome Susan Halli Demeter, SPRN, DNP, FNP-BC
9:15 AM CT	Inherited Genetic Lipid Disorders: An Overview Kathleen Byrne, MSN, CRNP, CCRN Megan Gwozdecke, Patient Advocate
10:00 AM CT	Primordial Prevention of Atherosclerosis: Starting Young Anne Goldberg, MD, FACP, FAHA
10:45 AM CT	Nutrition Interventions Across the Lifespan: A Case Study Approach Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
11:30 AM CT	Panel Discussion
12:00 PM CT	Break
12:15 PM CT	Women’s Lipid Health Across the Lifespan: An Unmet Need Eugenia Gianos, MD
1:00 PM CT	Access to Lipid Lowering Medications Eileen Handberg, PhD, ANP-BC, FACC Sheryl Zaworski, Patient Champion
1:45 PM CT	Panel Discussion
2:30 PM CT	Program Concludes

*Non-CE continuing education offers quality professional development that can be utilized in many work settings, for certification maintenance and more.

Learning Objectives

Inherited Genetic Lipid Disorders: An Overview

• Pathophysiology and effect of dyslipidemia
• Pharmacological management of dyslipidemia
• Case study of Familial Hypercholesterolemia and/or high triglycerides – a patient perspective

Primordial Prevention of Atherosclerosis: Starting Young

• Risk factors for developing dyslipidemia beginning in childhood
• Lifestyle and nutrition behavioral change principles
  Identification and monitoring of lipid disorders

Nutrition Interventions Across the Lifespan: A Case Study Approach

• Review of modifiable versus non-modifiable risk factors
• Metabolic syndrome, obesity, and diabetes
• Nutrition interventions to deploy for enhanced patient outcomes

• Women’s Lipid Health Across the Lifespan: An Unmet Need

• Lipids during peri-pregnancy period
• Dyslipidemia treatment considerations for contraception and fertility
• Menopause and aging effect on lipid status

Access to Lipid Lowering Medications

• Overview of novel lipid-lowering medications on the market today
• Effect of social determinants of health on access and adherence to lipid-lowering medications
• Shared decision making in access and adherence – a patient perspective

Thank you for the independent educational grant from Regeneron Pharmaceuticals, Inc.